Francisco J. Esteva: 5 common myths or misconceptions about cancer immunotherapy
Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology, Lenox Hill Hospital, shared a post on LinkedIn:
“Immunotherapy if one of the most important advances in cancer treatment. In this video, I discuss 5 common myths or misconceptions about cancer immunotherapy.”
Additional details.
Source: Francisco J. Esteva/LinkedIn
Francisco J. Esteva is the Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital. As the Director of Breast Cancer Translational Research for the Northwell Health Cancer Institute, his primary focus is bridging the gap between innovative laboratory discoveries and clinical applications to improve outcomes for breast cancer patients. His role encompasses leading a multidisciplinary team dedicated to advancing the understanding of breast cancer biology, genetics, and therapy.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023